Penicuik, United Kingdom
Biotangents Ltd is a biotechnology company founded in 2015 and headquartered in the United Kingdom. The company is focused on developing a new class of diagnostic device based on Moduleic Sensing™, a highly configurable proprietary technology for detecting specific nucleic acid sequences. This innovative approach is aimed at yielding a range of low-cost diagnostic tests for infectious diseases of livestock.
The company recently secured a £600.00K Venture Round investment on 18 May 2022, with the backing of notable investors including Scottish Enterprise and Kelvin Capital.
Biotangents' cutting-edge technology and potential to address crucial challenges in the agricultural and veterinary sectors make it an intriguing prospect for venture capitalists seeking opportunities in the biotech space. With its strong investor backing and groundbreaking approach, Biotangents is positioned for significant growth and impact in the coming years.
